Journal List > J Korean Ophthalmol Soc > v.57(3) > 1010528

Choi, Kim, Han, Lee, Cho, Lee, Kim, and Kim: Analysis of Referred 113 Patients with Endophthalmitis after Cataract Surgery and Associated Prognostic Factors

Abstract

Purpose

To evaluate factors affecting final visual acuity by analyzing patients referred with infectious endophthalmitis after cataract surgery.

Methods

A retrospective investigation of clinical notes of 113 patients referred with endophthalmitis following cataract surgery was conducted from January 2008 to December 2013. To evaluate factors affecting final visual acuity, initial visual acuity, onset of endophthalmitis after the cataract surgery, types of treatment, presence of hypopyon and culture results were investigated.

Results

Of the 113 patients, visual acuities at presentation were hand motions or less in 75 patients (66.3%) and final visual acuities after treatments were 0.5 or better in 73 patients (64.6%). Cases with initial visual acuity of hand motions or better achieved favorable outcomes whereas cases with gram-negative infection or endophthalmitis occurring within 2 days postoperatively showed poor prognosis. Statistically, vitrectomy versus intraocular antibiotic injection as primary means of treatment showed no differences in final visual acuity in patients with initial visual acuity of hand motion or better.

Conclusions

Visual acuities at presentation, type of cultured organism and onset of endophthalmitis after cataract surgery are significantly related to visual prognosis. Advantages of initial vitrectomy versus intraocular antibiotic injections were unclear and further investigations are necessary to clarify these issues.

References

1. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007; 33:978–88.
2. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. Arch Ophthalmol. 1991; 109:1085–9.
3. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
4. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998; 43:193–224.
crossref
5. Jeon CY, Lee TG, Na SJ. The clinical outcomes of 23-gauge trans-conjunctival sutureless vitrectomy for dndophthalmitis after cataract surgery. J Korean Ophthalmol Soc. 2011; 52:1167–72.
6. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995; 113:1479–96.
7. Pijl BJ, Theelen T, Tilanus MA, et al. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am J Ophthalmol. 2010; 149:482–7. e1-2.
crossref
8. Altan T, Acar N, Kapran Z, et al. Acute-onset endophthalmitis after cataract surgery: success of initial therapy, visual outcomes, and related factors. Retina. 2009; 29:606–12.
9. Ding Y, Lin M, Liu H, et al. Outcomes of post-cataract surgery endophthalmitis referred to a tertiary center from local hospitals in the south of China. Infection. 2011; 39:451–60.
crossref
10. Haapala TT, Nelimarkka L, Saari JM, et al. Endophthalmitis following cataract surgery in southwest Finland from 1987 to 2000. Graefes Arch Clin Exp Ophthalmol. 2005; 243:1010–7.
crossref
11. Ohl CA, Pollack M. Infections due to Pseudomonas species and related organisms. Harrisons Principles of Internal Medicine. 2005; 16:889.
12. Bohigian GM, Olk RJ. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986; 101:332–41.
crossref
13. Cheng JH, Chang YH, Chen CL, et al. Acute endophthalmitis after cataract surgery at a referral centre in Northern Taiwan: review of the causative organisms, antibiotic susceptibility, and clinical features. Eye (Lond). 2010; 24:1359–65.
crossref
14. Kent DG. Endophthalmitis in Auckland 1983–1991. Aust N Z J Ophthalmol. 1993; 21:227–36.
crossref
15. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol. 1997; 32:303–10.
16. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology. 2004; 111:699–705.
17. Kuhn F, Gini G. Ten years after… are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005; 243:1197–9.
crossref
18. Wejde G, Montan P, Lundström M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999–2001. Acta Ophthalmol Scand. 2005; 83:7–10.
crossref
19. Kang KT, Kim KS, Kim YC. Factors affecting final visual acuity in infectious endophthalmitis following cataract surgery. J Korean Ophthalmol Soc. 2013; 54:1025–31.
crossref
20. Jung JY, Ko BY, Kim BY. Factors associated with a poor visual result in acute endophthalmitis after cataract surgery. J Korean Ophthalmol Soc. 2008; 49:1242–7.
crossref
21. Kim WJ, Kweon EY, Lee DW, Cho NC. Postoperative endophthalmitis following cataract surgery over an eight-year period. J Korean Ophthalmol Soc. 2008; 49:1771–8.
crossref
22. Pinna A, Usai D, Sechi LA, et al. An outbreak of post-cataract surgery endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology. 2009; 116:2321–6. e1-4.
crossref
23. Lalwani GA, Flynn HW Jr, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996–2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008; 115:473–6.
24. Sandvig KU, Dannevig L. Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg. 2003; 29:1273–80.
crossref
25. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996; 122:830–46.

Figure 1.
Seasonal distribution of endophthalmitis after cataract surgery. The most likely month for patients to develop endophthalmitis was March.
jkos-57-420f1.tif
Table 1.
Summary of baseline patient characteristics
Characteristic Number (%) Mean ± SD (range)
Age (years) 70.3 ± 9.4 (41-96)
Gender
 Male 49 (43.4)
 Female 64 (56.6)
Involved eye
 Right 54 (47.8)
 Left 59 (52.2)
Presenting visual acuity
 LP or less 17 (15.0)
 HM 58 (51.3)
 FC (<20/400) 23 (20.4)
 ≥20/800 15 (13.3)
Mean follow up period (months) 15.5 ± 14.2 (2-76)
Time from surgery to presentation
 1-7 days 71 (62.8)
 >7 days 42 (37.2)
Type of ocular surgery
 Phacoemulsification 108 (95.6)
 ECCE or ICCE 5 (4.4)
Number of patients who received 30/113
 treatments before referral (26.5)
Posterior capsule status
 Intact 107 (94.7)
 Ruptured 6 (5.3)
Intraocular pressure 14.5 ± 6.5 (6-37)

Total 113

Values are presented as mean ± SD unless otherwise indicated. LP= light perception; HM= hand motions; FC= finger counts; ECCE= extracapsular cataract extraction; ICCE = intracapsular cataract extraction.

Table 2.
Type of treatments received before referral
Treatments Total count
IOAI only 23
IOAI with A/C irrigation 2
A/C irrigation 4
Primary vitrectomy 1

Total 30

IOAI = intraocular antibiotic injection; A/C = anterior chamber.

Table 3.
Microbiologic spectrum
Bacterial and fungal culture Total count
Gram-positive bacteria
Staphylococcus epidermidis 23
 MRSE 1
Streptococcus sanguinis 4
Streptococcus mitis 2
Enterococcus faecalis 10
Gram-negative bacteria
Pseudomonas aeruginosa 14
Acinetobacter baumannii 4
Serratia marcescens 2
Stenotrophomonas maltophilia 4

Total 63

MRSE = Methicillin-resistant Staphylococcus epidermidis.

Table 4.
Type of initial intervention according to presenting visual acuity
Presenting vision Initial intervention
Total
PPV + IOAI IOAI
LP 17 0 17
HM 36 22 58
Better than HM 15 23 38

Total 64 49 113

PPV = pars plana vitrectomy; IOAI = intraocular antibiotic injection, LP = light perception; HM = hand motions.

Table 5.
Comparison of final visual acuity after different types of treatments
Total count Final VA ≥ 0.50
p-value
n %
All cases 113 0.184*
 Primary vitrectomy 68 40 58.8
 Primary IOAI ± additional PPV 45 32 71.1
Cases with presenting VA of HM 58 0.985*
 Primary vitrectomy 36 23 63.8
 Primary IOAI ± additional PPV 22 14 63.6
Cases with presenting VA of FC 23 0.178
 Primary vitrectomy 9 8 88.9
 Primary IOAI ± additional PPV 14 9 63.6
Cases with presenting VA ≥ HM 96 0.876*
 Primary vitrectomy 51 37 72.5
 Primary IOAI ± additional PPV 45 32 71.1

VA = visual acuity; IOAI = intraocular antibiotics injection; PPV = pars plana vitrectomy; HM = hand motions; FC= finger counts.

* Pearson Chi-Square test;

Fisher's exact test.

Table 6.
Factors associated with visual outcome
Factor Final visual acuity
Significance of association (p-value)
Bettern than 20/200 (%) Worse than 20/200 (%)
Age (years) 0.244*
 Median (range) 70 (44-89) 70 (41-96)
Gender 0.057
 Male 34 (39.1) 15 (57.7)
 Female 53 (60.9) 11 (42.3)
Involved eye 0.981
 Right 42 (48.3) 12 (46.2)
 Left 45 (51.7) 14 (53.8)
Latency period 0.043
 <3 days 34 (39.1) 16 (61.5)
 ≥3 days 53 (60.9) 10 (38.5)
Time to presentation 0.172
 <7 days 79 (90.8) 21 (80.8)
 ≥7 days 8 (9.2) 5 (19.2)
Presenting visual acuity 0.001
 Light perception or less 7 (8.0) 10 (38.5)
 Hand motions or better 80 (92.0) 16 (61.5)
Hypopyon 0.565
 Yes 49 (56.3) 16 (61.5)
 No 38 (43.7) 10 (38.5)
Causative organism 0.030§
 Negative growth 42 (48.3) 8 (30.8)
 Gram-positive 31 (35.6) 8 (30.8)
 Gram-negative 14 (16.1) 10 (38.4)
Immediate vitrectomy 0.140
 Yes 46 (52.9) 18 (69.2)
 No 41 (47.1) 8 (30.8)

* Data expressed as median and range, and compared by Mann-Whitney's test;

Data expressed as count and percentage, and tested by the Chi-square test;

Data expressed as count and percentage, and tested by the Fisher's exact test;

§ Data expressed as count and percentage, and tested by the linear by linear association.

TOOLS
Similar articles